Expression of a retinoic acid signature in circulating CD34 cells from coronary artery disease patients

BMC Genomics

Volumn 11, Issue 1, 2010, Pages

  van der Pouw Kraan, Tineke C T M ^a   Schirmer, Stephan H ^b,c   Fledderus, Joost O ^b   Moerland, Perry D ^b   Baggen, Josefien M ^a   Leyen, Thomas A ^a   van der Laan, Anja M ^b   Piek, Jan J ^b   van Royen, Niels ^b   Horrevoets, Anton J G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CD14 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; HISTONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN HOXA5; PROTEIN KRAB; RETINOIC ACID; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXA9; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC ANALYSIS; GENETIC CORRELATION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; MACROPHAGE; MONOCYTE; MONONUCLEAR CELL; PHENOTYPE; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; BLOOD; CASE CONTROL STUDY; CELL DIFFERENTIATION; CELL MOTION; GENETICS; GENOMICS; METABOLISM; PATHOLOGY; STEM CELL;

ANTIGENS, CD34; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL MOVEMENT; CORONARY ARTERY DISEASE; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; PHENOTYPE; STEM CELLS; TRETINOIN;

EID: 77953666064     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-11-388     Document Type: Article

References (43)

1. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Jung S, et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006, 124:175-189. 10.1016/j.cell.2005.10.036, 16413490.
2. Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H, et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 2004, 114:330-338. 484977, 15286799.
3. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001, 32:2682-2688. 10.1161/hs1101.098367, 11692034.
4. Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, Zeiher AM, et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 2005, 39:733-742. 10.1016/j.yjmcc.2005.07.003, 16199052.
5. Reffelmann T, Konemann S, Kloner RA. Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy. J Am Coll Cardiol 2009, 53:305-308. 10.1016/j.jacc.2008.10.018, 19161877.
6. van der LA, Hirsch A, Nijveldt R, van d V, van der Giessen WJ, Doevendans PA, et al. Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Neth Heart J 2008, 16:436-439. 2612115, 19127324.
7. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005, 353:999-1007. 10.1056/NEJMoa043814, 16148285.
8. Fadini GP, Coracina A, Baesso I, Agostini C, Tiengo A, Avogaro A, et al. Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke 2006, 37:2277-2282. 10.1161/01.STR.0000236064.19293.79, 16873710.
9. Whittaker A, Moore JS, Vasa-Nicotera M, Stevens S, Samani NJ. Evidence for genetic regulation of endothelial progenitor cells and their role as biological markers of atherosclerotic susceptibility. Eur Heart J 2008, 29:332-338. 10.1093/eurheartj/ehm602, 18192701.
10. Schirmer SH, Fledderus JO, van der Laan AM, van der Pouw-Kraan TC, Moerland PD, Volger OL, et al. Suppression of inflammatory signaling in monocytes from patients with coronary artery disease. J Mol Cell Cardiol 2009, 46:177-185. 10.1016/j.yjmcc.2008.10.029, 19059264.
11. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001, 98:5116-5121. 10.1073/pnas.091062498, 33173, 11309499.
12. Hemmoranta H, Hautaniemi S, Niemi J, Nicorici D, Laine J, Yli-Harja O, et al. Transcriptional profiling reflects shared and unique characters for CD34+ and CD133+ cells. Stem Cells Dev 2006, 15:839-851. 10.1089/scd.2006.15.839, 17253947.
13. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102:15545-15550. 10.1073/pnas.0506580102, 1239896, 16199517.
14. Chen H, Rubin E, Zhang H, Chung S, Jie CC, Garrett E, et al. Identification of transcriptional targets of HOXA5. J Biol Chem 2005, 280:19373-19380. 10.1074/jbc.M413528200, 15757903.
15. Georgantas RW, Tanadve V, Malehorn M, Heimfeld S, Chen C, Carr L, et al. Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells. Cancer Res 2004, 64:4434-4441. 10.1158/0008-5472.CAN-03-3247, 15231652.
16. Wettschureck N, Offermanns S. Mammalian G proteins and their cell type specific functions. Physiol Rev 2005, 85:1159-1204. 10.1152/physrev.00003.2005, 16183910.
17. Urrutia R. KRAB-containing zinc-finger repressor proteins. Genome Biol 2003, 4:231. 10.1186/gb-2003-4-10-231, 328446, 14519192.
18. O'Geen H, Squazzo SL, Iyengar S, Blahnik K, Rinn JL, Chang HY, et al. Genome-wide analysis of KAP1 binding suggests autoregulation of KRAB-ZNFs. PLoS Genet 2007, 3:e89. 10.1371/journal.pgen.0030089, 1885280,1885280, 17542650.
19. Argiropoulos B, Humphries RK. Hox genes in hematopoiesis and leukemogenesis. Oncogene 2007, 26:6766-6776. 10.1038/sj.onc.1210760, 17934484.
20. Rossig L, Urbich C, Bruhl T, Dernbach E, Heeschen C, Chavakis E, et al. Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells. J Exp Med 2005, 201:1825-1835. 10.1084/jem.20042097, 2213253, 15928198.
21. Turjanski AG, Vaque JP, Gutkind JS. MAP kinases and the control of nuclear events. Oncogene 2007, 26:3240-3253. 10.1038/sj.onc.1210415, 17496919.
22. McKinsey TA, Zhang CL, Olson EN. MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci 2002, 27:40-47. 10.1016/S0968-0004(01)02031-X, 11796223.
23. Seeger FH, Rasper T, Koyanagi M, Fox H, Zeiher AM, Dimmeler S. CXCR4 Expression Determines Functional Activity of Bone Marrow-Derived Mononuclear Cells for Therapeutic Neovascularization in Acute Ischemia. Arterioscler Thromb Vasc Biol 2009, %20.
24. Walter DH, Haendeler J, Reinhold J, Rochwalsky U, Seeger F, Honold J, et al. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 2005, 97:1142-1151. 10.1161/01.RES.0000193596.94936.2c, 16254213.
25. Yang FC, Atkinson SJ, Gu Y, Borneo JB, Roberts AW, Zheng Y, et al. Rac and Cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration, and mobilization. Proc Natl Acad Sci USA 2001, 98:5614-5618. 10.1073/pnas.101546898, 33261, 11320224.
26. Ren X, Ma X, Li Y. All-trans retinoic acid regulates c-jun expression via ERK5 in cardiac myoblasts. J Nutr Biochem 2007, 18:832-838. 10.1016/j.jnutbio.2006.12.023, 17509854.
27. Okamoto S, Krainc D, Sherman K, Lipton SA. Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation. Proc Natl Acad Sci USA 2000, %20;97:7561-7566.
28. Bi W, Ohyama T, Nakamura H, Yan J, Visvanathan J, Justice MJ, et al. Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith-Magenis syndrome. Hum Mol Genet 2005, 14:983-995. 10.1093/hmg/ddi085, 15746153.
29. Tsuzuki S, Kitajima K, Nakano T, Glasow A, Zelent A, Enver T. Cross talk between retinoic acid signaling and transcription factor GATA-2. Mol Cell Biol 2004, 24:6824-6836. 10.1128/MCB.24.15.6824-6836.2004, 444844, 15254248.
30. Connelly JJ, Wang T, Cox JE, Haynes C, Wang L, Shah SH, et al. GATA2 is associated with familial early-onset coronary artery disease. PLoS Genet 2006, 2:1265-1273.
31. Escribese MM, Conde E, Saenz-Morales D, Hordijk PL, Garcia-Bermejo ML. Mononuclear cell extravasation in an inflammatory response is abrogated by all-trans-retinoic acid through inhibiting the acquisition of an appropriate migratory phenotype. J Pharmacol Exp Ther 2008, 324:454-462. 10.1124/jpet.107.127225, 17977980.
32. Schmidt CK, Brouwer A, Nau H. Chromatographic analysis of endogenous retinoids in tissues and serum. Anal Biochem 2003, 315:36-48. 10.1016/S0003-2697(02)00662-0, 12672410.
33. Kane MA, Folias AE, Wang C, Napoli JL. Quantitative profiling of endogenous retinoic acid in vivo and in vitro by tandem mass spectrometry. Anal Chem 2008, 80:1702-1708. 10.1021/ac702030f, 18251521.
34. Chute JP, Muramoto GG, Whitesides J, Colvin M, Safi R, Chao NJ, et al. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci USA 2006, 103:11707-11712. 10.1073/pnas.0603806103, 1544234, 16857736.
35. Purton LE. Roles of Retinoids and Retinoic Acid Receptors in the Regulation of Hematopoietic Stem Cell Self-Renewal and Differentiation. PPAR Research 2007, 2007:1-7.
36. Purton LE, Bernstein ID, Collins SJ. All-trans retinoic acid delays the differentiation of primitive hematopoietic precursors (lin-c-kit+Sca-1(+)) while enhancing the terminal maturation of committed granulocyte/monocyte progenitors. Blood 1999, 94:483-495.
37. Papaspyridonos M, Smith A, Burnand KG, Taylor P, Padayachee S, Suckling KE, et al. Novel candidate genes in unstable areas of human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2006, 26:1837-1844. 10.1161/01.ATV.0000229695.68416.76, 16741146.
38. Smyth GK, Speed T. Normalization of cDNA microarray data. Methods 2003, 31:265-273. 10.1016/S1046-2023(03)00155-5, 14597310.
39. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5:R80. 10.1186/gb-2004-5-10-r80, 545600, 15461798.
40. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264. 10.1093/biostatistics/4.2.249, 12925520.
41. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193. 10.1093/bioinformatics/19.2.185, 12538238.
42. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998, 95:14863-14868. 10.1073/pnas.95.25.14863, 24541, 9843981.
43. Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, Rabkin S, et al. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 2005, 33:D284-D288. 10.1093/nar/gki078, 540032, 15608197.